A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus
We are currently faced with a global infectious disease crisis which has been anticipated for decades. While many promising biotherapeutics are being tested, the search for a small molecule has yet to deliver an approved drug or therapeutic for the Ebola or similar filoviruses that cause haemorrhagi...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
F1000Research
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304229/ |